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Bone morphogenic proteins (BMPs) act as inducers of diverse cellular fates in human embryonic stem cells,
but the mechanisms responsible remain poorly understood. In this issue of Cell Stem Cell, Bernardo et al.
(2011) demonstrate that different BMP-induced differentiation programs may be orchestrated by similar
key target genes.The first differentiation event in mamma-
lian development takes place at the mor-
ula stage, when the cells of the embryo
segregate into two major lineages: (1) the
inner cell mass, which will give rise to the
embryo proper, and (2) the surrounding
trophectoderm, which will form the em-
bryonic parts of the placenta. There are
key transcription factors involved in this
segregation process, such as NANOG,
which becomes restricted to the inner
cell mass, and CDX2, which is crucial for
establishing the trophoblast lineage (Stru-
mpf et al., 2005). After the two lineages
have formed, cells do not cross this
boundary at any later stage during de-
velopment. Accordingly, mouse embry-
onic stem cells (ESCs), which are de-
rived from the inner cell mass, do not
normally differentiate into trophoblasts
in vitro. Strikingly, however, the Thom-
son group reported that human ESCs
(hESCs), unlike mouse ESCs (mESCs),
are capable of differentiating into pla-
cental hormone-secreting syncytiotro-
phoblast-like cells following stimulation
with recombinant BMP4 (Xu et al., 2002),
a finding that has also been reproduced
by others.
It is now generally accepted that,
despite their blastocyst origin, hESCs
resemble postimplantation epiblasts, be-
cause they share a number of characteris-
tics with mouse epiblast stem cells thatare directly derived from this pluripotent
tissue. One such hallmark is strong re-
sponsiveness to BMP stimulation, and
BMP signaling is crucial for mesoderm
formation during gastrulation. Indeed, re-
combinant BMP addition is frequently
applied to inducemesodermal differentia-
tion in hESCs (Murry and Keller, 2008).
BMP responsiveness and overall simi-
larity to epiblast tissue, however, still do
not provide a straightforward explana-
tion for why hESCs would also generate
trophoblast in response to BMP, because
the in vivo epiblast does not do that either.
In a comprehensive study in this issue of
Cell Stem Cell, Bernardo et al. (2011)
now address how different cellular fates
are induced by BMP in hESCs. Together
with independent results by Yu et al.
(2011), the data shed new light on the
mechanisms involved and revise the roles
of seemingly established ‘‘marker genes’’
in this context.
The first key observation made is that
cell fate following BMP4 stimulation of
hESCs is critically modulated by the pres-
ence or absence of fibroblast growth
factor 2 (FGF2). FGF2 is included in virtu-
ally all hESC media and serves, at least in
part, to sustain expression of the self-
renewal controlling transcription factor
NANOG (Figure 1A; Greber et al., 2010;
Yu et al., 2011). When combining BMP4
and FGF2, however, prominent playersinvolved in mesoderm formation, notably
Brachyury (also known as T), became
strongly induced. Interestingly, the con-
tributing effect by FGF2 in this joint
effort was mediated through NANOG,
as NANOG overexpression in BMP4-
without-FGF2 media caused Brachyury
induction, and NANOG silencing in
BMP4-plus-FGF2 media interfered with
it (Yu et al., 2011). These findings, com-
bined with independent data, support a
revised view of how pluripotency is
controlled. In this model, individual core
transcription factors such as NANOG not
only preserve the undifferentiated state
by activating other ESC-specific genes
and repressing certain lineage inducers.
In addition, they may also actively partici-
pate in promoting differentiation into
specific fates, in collaboration with sig-
naling cues such as BMP in the case of
mesoderm specification (Figures 1A and
1B; Boyer et al., 2005; Loh and Lim, 2011;
Teo et al., 2011; Thomson et al., 2011).
Bernardo et al. also find that the tran-
scription factor CDX2 is required for
mesoderm formation downstream of T,
because CDX2 ablation under BMP4-
plus-FGF2 conditions strongly interfered
with the induction of prominent genes
conferring mesoderm identity (Figure 1B).
This is a surprising and important find-
ing, given that CDX2 has commonly been
associated with extraembryonic—notll 9, August 5, 2011 ª2011 Elsevier Inc. 91
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Figure 1. Control of Fate Decisions in hESCs by BMP and FGF
(A–C) Combined results from Yu et al. (2011) and Bernardo et al. (2011). Dashed lines denote direct or
indirect mechanisms.
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CDX2 upregulation in differentiating hESC
cultures always needs to be interpreted
with caution. Bernardo and colleagues
then asked: if expression of classical
trophoblast genes such as CDX2 may
actually reflect mesoderm induction in
hESCs, then what about the identity of
cells exposed to BMP alone? In detailed
analyses, using not only hESCs but also
mouse epiblast stem cells and epiblast
explants, they first confirm the induction
of extraembryonic fate under these
conditions. As expected, conventional
trophoblast markers became strongly
induced. This pattern was severely com-
promised inCDX2knockdowncells,which
confirmed the suspicion that CDX2 plays
crucial roles in both mesodermal and
extraembryonic differentiation (Figures
1B and 1C). On the other hand, using
FACS analysis, Bernardo et al. strikingly
detected coexpression of markers for92 Cell Stem Cell 9, August 5, 2011 ª2011 El(extraembryonic) mesoderm in otherwise
trophoblast-like cells. Based on these
and other observations, Bernardo and
colleagues argue against a bona fide
trophoblast identity of BMP4-differenti-
atedhESCsand interpret their data in favor
of extraembryonic mesoderm fate instead
(Figure 1C). This conclusion is also sup-
ported by intriguing gene silencing data
implying theprototype somaticmesoderm
factor Brachyury in BMP-induced extra-
embryonic differentiation. Well-known
effects inducedbycontinuousBMPstimu-
lation, such as the formation of syncytia
andplacental hormoneproduction,would,
however, be more compatible with syn-
cytiotrophoblast than extraembryonic
mesoderm identity. In future studies, it
will therefore be important to reveal
parameters that may favor one extraem-
bryonic cell lineage at the expense of
another, to exclude the rather unpleasant
possibility of generating cell types withoutsevier Inc.a clear in vivo counterpart. For instance,
data by Yu et al. (2011) suggest that the
BMP dosage applied may be one such
critical parameter (Figure 1C). It will also
be interesting to see whether blockage of
autocrine FGF signaling would encourage
genuine trophoblast identity, as this treat-
ment should prevent any induction of
Brachyury (Figure 1B).REFERENCES
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